Results

Kilitch Drugs (India) Ltd. - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended December 31, 2018 And To Consider The Appointment Of CA Sujit Kumar Dash As A Chief Financial Officer Of The Company.

| Updated on February 05, 2019 Published on February 05, 2019

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve 1.To consider and approve the un-audited financial results of the company for the quarter ended December 31, 2018.

2.To consider the resignation of Mr. Shailesh Mirgal as a Chief Financial Officer of the Company.

3.To consider the appointment of CA Sujit Kumar Dash as a Chief Financial Officer of the Company.

4.To consider the appointment of M/s. Deep Shukla & Associates, Company Secretaries to conduct Secretarial Audit of the Company for financial year ended 31st March, 2019.

5.Any other matter with the permission of the chair.

Pdf Link: Kilitch Drugs (India) Ltd. - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended December 31, 2018 And To Consider The Appointment Of CA Sujit Kumar Dash As A Chief Financial Officer Of The Company.

Source : BSE - www.bseindia.com

Published on February 05, 2019
This article is closed for comments.
Please Email the Editor